Merck handed Aspen the right to make a once-monthly HIV pill across 129 countries. It is the second pharma prize Africa's largest drugmaker has landed this month.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.